Theriva Biologics (TOVX) has announced a public offering of up to 1,428,600 shares at $1.75 per share, aiming to raise approximately $2.5 million. The funds will be allocated for working capital, research and development, and manufacturing scale-up. The accompanying warrants have an exercise price of $2.00 and will expire in five years.